|
Zinc dysregulation as a druggable target in human skin photocarcinogenesis
|
1R03CA230949-01
|
$73,677
|
WONDRAK, GEORG
|
UNIVERSITY OF ARIZONA
|
|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-05
|
$347,563
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Yoga Versus CBT-I for Insomnia in Cancer Survivors and Biobehavioral Mechanisms
|
5R01CA181064-05
|
$593,588
|
MUSTIAN, KAREN
|
UNIVERSITY OF ROCHESTER
|
|
Yoga Intervention for Family Caregivers of Patients with Brain Tumors
|
1R21CA218309-01A1
|
$174,000
|
MILBURY, KATHRIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Yap and beta-catenin interactions in liver: Implications in Pathophysiology
|
5R01CA204586-03
|
$416,268
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Yale SPORE in Skin Cancer
|
2P50CA121974-11A1
|
$2,500,000
|
BOSENBERG, MARCUS
|
YALE UNIVERSITY
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-04
|
$2,507,598
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$531,469
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
5K08CA218460-02
|
$106,531
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
5P50CA211024-02
|
$2,283,108
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Weight cycling and total and site-specific cancer incidence and mortality
|
5R03CA204825-02
|
$79,500
|
GIOVANNUCCI, EDWARD
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Web-based Physical Activity Intervention for Children with ALL
|
5R01CA193478-03
|
$826,706
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
5F31CA213901-02
|
$44,524
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-03
|
$2,300,000
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
VU PREDICT
|
1U24CA220325-01A1
|
$664,613
|
MANNING, HENRY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Virtual Transportation as a Strategy to Reduce Resistance to Cigarette and e-Cigarette Graphic Health Warnings in Adolescents and Young Adults
|
5R01CA214587-03
|
$363,195
|
BLANTON, HART
|
TEXAS A&M UNIVERSITY
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-04
|
$334,911
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Vermont Breast Cancer Molecular Characterization Laboratory
|
5U01CA196383-04
|
$312,000
|
STEIN, JANET
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-03S2
|
$65,611
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-03
|
$341,981
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,186,781
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-05
|
$497,934
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Vanderbilt Training Program in Molecular and Genetic Epidemiology of Cancer
|
5T32CA160056-08
|
$435,520
|
SHU, XIAO-OU
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Vanderbilt Clinical Oncology Research Career Development Award
|
5K12CA090625-19
|
$961,183
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases
|
2R42CA206744-02A1
|
$665,919
|
MCCABE, AARON
|
MINNETRONIX, INC.
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
4UH3CA206124-03
|
$423,750
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-03
|
$1,563,388
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation of a novel, adjuvant implant for post-metastatic skeletal lesions
|
1R43CA221553-01A1
|
$299,958
|
MARGULIES, BRYAN
|
FUSOLOGICS, LLC
|
|
Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer
|
1R21CA218973-01A1
|
$203,042
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Validation and translation of a non-invasive, MR-guided breast cancer therapy
|
1R37CA224141-01
|
$513,511
|
PAYNE, ALLISON
|
UNIVERSITY OF UTAH
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
|
5R01CA154823-07
|
$641,991
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$532,008
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$532,008
|
Hodge, James
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy
|
1K99CA230384-01
|
$107,860
|
HOPKINS, BENJAMIN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Utilizing Nucleic-Acid Scavengers to Ameliorate Inflammation-driven Metastatic Progression in Breast Cancer
|
1F31CA232394-01
|
$35,885
|
ETESHOLA, ELIAS
|
DUKE UNIVERSITY
|
|
Utilizing MEK Inhibition to Sensitize Microsatellite Stable Colorectal Cancer to Immune Checkpoint Therapy
|
1R01CA229259-01
|
$247,340
|
LIEU, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
Using Zebrafish to Identify and Analyze Cancer Genes
|
5R01CA106416-03
|
$398,901
|
Lees, Jacqueline
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-05
|
$379,294
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients
|
5R01CA193706-03
|
$554,574
|
WYATT, GWEN
|
MICHIGAN STATE UNIVERSITY
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
5R21CA208921-02
|
$167,475
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
Using patient-derived models to understand drug responses in SCLC
|
1U01CA220323-01A1
|
$619,923
|
DYSON, NICHOLAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Using hunger training to enhance weight loss and modulate cancer-related biomarkers in women at high risk for breast cancer: a pilot study
|
5R21CA215415-02
|
$174,000
|
BASEN-ENGQUIST, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using Functional Genomics to Inform Gene Environment Interactions for Colorectal Cancer
|
3R01CA201407-02S1
|
$32,686
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Using functional genomics to inform gene environment interactions for colorectal cancer
|
5R01CA201407-03
|
$1,867,631
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-05
|
$323,700
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
Z01 BC 005673
|
$1,225,024
|
Keefer, Larry
|
CCR (NCI)
|
|
Using Community-Engaged Methods to Design a Tool to Promote Informed Breast Cancer Screening Decisions for Low Literacy Women
|
1K07CA221899-01A1
|
$129,704
|
GUNN, CHRISTINE
|
BOSTON MEDICAL CENTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|